Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children

J Med Virol. 2018 Jul;90(7):1222-1231. doi: 10.1002/jmv.25074. Epub 2018 Apr 6.

Abstract

B-cells play an important role in defending children against various infections. In view of scare data, we undertook this prospective cohort study to describe B cell compartment in HIV infected children (<5 years of age) and the effect of HAART on B cell subpopulations. HIV infected children (<5 years) from Pediatric HIV services of the Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, were recruited (April 2012-December 2015). The enrolled HIV-1 infected children (n = 59) were followed up regularly for 12 months; healthy controls (n = 51) included HIV uninfected children with no major illness. Flow cytometry was performed on fresh EDTA-treated blood samples to characterize B cell subpopulations. In HIV-infected children, marked depletion of naive (P = 0.003), non-switched memory (P = 0.02), mature (P = 0.0005), resting memory (P < 0.0001) B cells, and expansion of double negative memory (P < 0.0001), activated memory (P < 0.0001) and tissue like memory (P < 0.0001) B cells were observed as compared to healthy controls. In children started on HAART, at the end of 12 months of therapy, frequencies of non-switched memory (P = 0.04), switched memory (P = 0.01), and resting memory (P = 0.003) B cells were lower; activated memory (P = 0.04), and tissue-like memory (P = 0.0001) B cells were still higher than healthy controls. HIV infection resulted in reduced memory B cells in HIV infected children. Following HAART, there was normalization of some B cell subpopulations. The study emphasizes the need of re-vaccination in HIV infected children to maintain the memory B cell pool and adequate humoral immune response against infections.

Keywords: activation; apoptosis; exhaustion; partial reconstitution.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • B-Lymphocyte Subsets / immunology*
  • B-Lymphocytes / immunology*
  • Child, Preschool
  • Female
  • Flow Cytometry
  • Follow-Up Studies
  • HIV Infections / drug therapy*
  • HIV Infections / pathology*
  • HIV-1 / isolation & purification
  • Humans
  • India
  • Infant
  • Male
  • Prospective Studies
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents